Resources

Selected
  • 烽火通讯股价突破30元可能性分析
Type of publications
Regions
Diseases
446 results found
2023 ∙ Ng, C. L. Tay, E. Y. D'Souza, A. R.
Localised swelling at sites of dermal filler injections following administration of Covid-19 vaccines: a systematic review
Adults COVID-19 Safety
Rating:
Critically low
2023 ∙ Saputra, P. B. T. Kurniawan, R. B. Trilistyoati, D. Farabi, M. J. A. Susilo, H. Alsagaff, M. Y. Oktaviono, Y. H. Sutanto, H. Gusnanto, A. Dyah Kencono Wungu, C.
Myocarditis and coronavirus disease 2019 vaccination: A systematic review and meta-summary of cases
All age groups COVID-19 Safety
Rating:
Low
2023 ∙ Di Spirito, F. Pantaleo, G. Di Palo, M. P. Amato, A. Raimondo, A. Amato, M.
Oral Human Papillomavirus Benign Lesions and HPV-Related Cancer in Healthy Children: A Systematic Review
Adolescents Human papillomavirus (HPV) Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Ishisaka, Y. Watanabe, A. Aikawa, T. Kanaoka, K. Takagi, H. Wiley, J. Yasuhara, J. Kuno, T.
Overview of SARS-CoV-2 infection and vaccine associated myocarditis compared to non-COVID-19-associated myocarditis: A systematic review and meta-analysis
All age groups COVID-19 Safety
Rating:
Critically low
2023 ∙ Liu, Y. Kuang, K.
Predictors of COVID-19 vaccination hesitancy in China: a meta-analysis
Western Pacific China All age groups COVID-19 Acceptance
Rating:
Not applicable
2023 ∙ Bianchi, Francesco Paolo Stefanizzi, Pasquale Migliore, Giovanni Martinelli, Andrea Vimercati, Luigi Germinario, Cinzia Annatea Tafuri, Silvio
Prevalence of healthcare workers fully vaccinated against hepatitis B without circulating antibodies in Italy and role of age at baseline cycle vaccination: a systematic review and meta-analysis
Europe Italy Healthcare workers Hepatitis B Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Rahman, M. O. Kamigaki, T. Thandar, M. M. Haruyama, R. Yan, F. Shibamura-Fujiogi, M. Khin Maung Soe, J. Islam, M. R. Yoneoka, D. Miyahara, R. Ota, E. Suzuki, M.
Protection of the third-dose and fourth-dose mRNA vaccines against SARS-CoV-2 Omicron subvariant: a systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Low
2023 ∙ Dinga, J. N. Kabakama, S. Njimoh, D. L. Chia, J. E. Morhason-Bello, I. Lumu, I.
Quantitative Synthesis of Factors Associated with COVID-19 Vaccine Acceptance and Vaccine Hesitancy in 185 Countries
All age groups COVID-19 Acceptance
Rating:
Not applicable
2023 ∙ Cheng, M. Q. Li, R. Weng, Z. Y. Song, G.
Relative effectiveness of bivalent COVID-19 vaccine: a systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Silva, P. B. R. Silva, G. D.
Risk and characteristics of attacks occurring after vaccination in patients with neuromyelitis optica spectrum disorders: A systematic review and meta-analysis
All age groups Safety
Rating:
Critically low
Loading...